Nguyen Anna, Ondrus Alison E
Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60607, United States.
Department of Chemistry, University of Illinois Chicago, Chicago, Illinois 60607, United States.
J Med Chem. 2024 Dec 12;67(23):20765-20775. doi: 10.1021/acs.jmedchem.4c01885. Epub 2024 Dec 1.
Cholesterol is structurally distinct from other lipids, which confers it with singular roles in membrane organization and protein function. As a signaling molecule, cholesterol engages in discrete interactions with transmembrane, peripheral, and certain soluble proteins to control cellular responses. Accordingly, the cholesterol-protein interface is central to cholesterol-related diseases and is an essential consideration in drug design. However, cholesterol's hydrophobic, un-drug-like nature presents a unique challenge to traditional analyses. In this Perspective, we survey a collection of tools designed to predict and evaluate cholesterol binding sites in proteins, including classical sequence motifs, molecular docking, template-based strategies, molecular dynamics simulations, and recent artificial intelligence approaches. We then comment on contemporary tools to evaluate ligand-protein interactions, their applicability to cholesterol, and the yet-untapped potential of cholesterol-protein interactions in human health and disease.
胆固醇在结构上与其他脂质不同,这使其在膜组织和蛋白质功能中具有独特作用。作为一种信号分子,胆固醇与跨膜蛋白、外周蛋白及某些可溶性蛋白进行特定相互作用,以控制细胞反应。因此,胆固醇 - 蛋白质界面是胆固醇相关疾病的核心,也是药物设计中必不可少的考虑因素。然而,胆固醇的疏水性、非药物样性质给传统分析带来了独特挑战。在这篇观点文章中,我们综述了一系列旨在预测和评估蛋白质中胆固醇结合位点的工具,包括经典序列基序、分子对接、基于模板的策略、分子动力学模拟以及最近的人工智能方法。然后,我们评论了评估配体 - 蛋白质相互作用的当代工具、它们对胆固醇的适用性,以及胆固醇 - 蛋白质相互作用在人类健康和疾病中尚未开发的潜力。